decisionhealth Newsletters, Coder Pink Sheets - 2003 Issue 1 (January)
Drug fee schedule
Subscribe or sign in to view the full article.
Article Overview
This article explains a CMS update that established national pricing for a set of Medicare-payable drugs administered in physician offices. It is relevant to physician-office billing staff, coders, and ObGyn practices that report injectable drug claims under Medicare Part B. The article provides a sample of office-administered drugs, the HCPCS identifiers used for billing, and the general context for how the new fee schedule affects reimbursement.
Why This Topic Matters
It helps billing and coding professionals understand a national Medicare payment update affecting office-administered drugs and the HCPCS identifiers associated with those drugs.
What You Will Learn
- What the CMS national fee schedule update covers
- How the article frames Medicare reimbursement for office-administered drugs
- Which ObGyn office injectable drugs are included in the sample list
- What billing code set is used for the drug schedule table
Who Should Read This
- Medical coders
- Billing specialists
- Physician office staff
- ObGyn practices
- Medicare billing personnel
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com